Fempower Health

“Women have been socialized to accept suffering—from cramps to chronic pain—and that affects how they show up for care.” — Dr. Sharon Malone

Progesterone and progestins are often used as if they mean the same thing — but they’re not. In this episode, two leading hormone experts unpack how this mix-up shaped menopause care, research, and what every woman needs to know about getting the right treatment.

The FDA recently held a rare public hearing on menopause, and experts—including Dr. James Simon—say hormone therapy labels no longer reflect today’s science. In this Fempower Health episode, Georgie Kovacs explores what the FDA heard, why estrogen and testosterone access remain limited, and how these decisions affect women’s real-world care and confidence in their health choices.

“AI is only as good as the data it’s trained on. And right now, women’s health data is dangerously thin. If we don’t fix that gap, AI could end up repeating the same mistakes women already face in the exam room — being overlooked, dismissed, or misdiagnosed. But if we get it right, AI could finally help women advocate for themselves and bring truly personalized care into reality...

Women are often left to self-navigate a healthcare system full of cracks — especially in midlife. In this episode, Georgie Kovacs speaks with Joanna Strober, CEO of Midi Health, about the systemic barriers in women’s health, from reimbursement to research gaps, and what it will take to drive real innovation.